Tags

Type your tag names separated by a space and hit enter

Update: Interim Guidance for Prevention of Sexual Transmission of Zika Virus--United States, 2016.

Abstract

CDC issued interim guidance for the prevention of sexual transmission of Zika virus on February 5, 2016. The following recommendations apply to men who have traveled to or reside in areas with active Zika virus transmission and their female or male sex partners. These recommendations replace the previously issued recommendations and are updated to include time intervals after travel to areas with active Zika virus transmission or after Zika virus infection for taking precautions to reduce the risk for sexual transmission. This guidance defines potential sexual exposure to Zika virus as any person who has had sex (i.e., vaginal intercourse, anal intercourse, or fellatio) without a condom with a man who has traveled to or resides in an area with active Zika virus transmission. This guidance will be updated as more information becomes available.

Links

  • FREE Publisher Full Text
  • Authors

    , , , , , , , ,

    Source

    MeSH

    Centers for Disease Control and Prevention (U.S.)
    Condoms
    Female
    Guidelines as Topic
    Humans
    Male
    Mass Screening
    Pregnancy
    Residence Characteristics
    Sexual Abstinence
    Sexually Transmitted Diseases, Viral
    Travel
    United States
    Zika Virus Infection

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    27032078

    Citation

    Oster, Alexandra M., et al. "Update: Interim Guidance for Prevention of Sexual Transmission of Zika Virus--United States, 2016." MMWR. Morbidity and Mortality Weekly Report, vol. 65, no. 12, 2016, pp. 323-5.
    Oster AM, Russell K, Stryker JE, et al. Update: Interim Guidance for Prevention of Sexual Transmission of Zika Virus--United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(12):323-5.
    Oster, A. M., Russell, K., Stryker, J. E., Friedman, A., Kachur, R. E., Petersen, E. E., ... Brooks, J. T. (2016). Update: Interim Guidance for Prevention of Sexual Transmission of Zika Virus--United States, 2016. MMWR. Morbidity and Mortality Weekly Report, 65(12), pp. 323-5. doi:10.15585/mmwr.mm6512e3.
    Oster AM, et al. Update: Interim Guidance for Prevention of Sexual Transmission of Zika Virus--United States, 2016. MMWR Morb Mortal Wkly Rep. 2016 Apr 1;65(12):323-5. PubMed PMID: 27032078.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Update: Interim Guidance for Prevention of Sexual Transmission of Zika Virus--United States, 2016. AU - Oster,Alexandra M, AU - Russell,Kate, AU - Stryker,Jo Ellen, AU - Friedman,Allison, AU - Kachur,Rachel E, AU - Petersen,Emily E, AU - Jamieson,Denise J, AU - Cohn,Amanda C, AU - Brooks,John T, Y1 - 2016/04/01/ PY - 2016/4/1/entrez PY - 2016/4/1/pubmed PY - 2016/8/5/medline SP - 323 EP - 5 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb. Mortal. Wkly. Rep. VL - 65 IS - 12 N2 - CDC issued interim guidance for the prevention of sexual transmission of Zika virus on February 5, 2016. The following recommendations apply to men who have traveled to or reside in areas with active Zika virus transmission and their female or male sex partners. These recommendations replace the previously issued recommendations and are updated to include time intervals after travel to areas with active Zika virus transmission or after Zika virus infection for taking precautions to reduce the risk for sexual transmission. This guidance defines potential sexual exposure to Zika virus as any person who has had sex (i.e., vaginal intercourse, anal intercourse, or fellatio) without a condom with a man who has traveled to or resides in an area with active Zika virus transmission. This guidance will be updated as more information becomes available. SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/27032078/Update:_Interim_Guidance_for_Prevention_of_Sexual_Transmission_of_Zika_Virus__United_States_2016_ L2 - https://dx.doi.org/10.15585/mmwr.mm6512e3 DB - PRIME DP - Unbound Medicine ER -